Osborne Clarke advises UCL Technology Fund on lead investment in Bloomsbury Genetic Therapies' £5m financing round
Bloomsbury Genetic Therapies Limited ("Bloomsbury"), a clinical-stage biotechnology company developing potentially curative treatments for patients suffering from rare neurological and...
Published on
13/01/2023
Read time
1m